Insmed (INSM) News Today $72.30 -0.34 (-0.47%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$72.68 +0.38 (+0.52%) As of 05/2/2025 05:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Insmed Incorporated (INSM): Among the Large-Cap Stocks Insiders and Short Sellers Are Dumping Like CrazyMay 4 at 12:55 PM | insidermonkey.comInsmed Incorporated (INSM): Among the Large-Cap Stocks Insiders and Short Sellers Are Dumping Like CrazyMay 4 at 12:13 PM | finance.yahoo.com10,000 Shares in Insmed Incorporated (NASDAQ:INSM) Bought by Allostery Investments LPAllostery Investments LP acquired a new position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 10,000 shares of the biophMay 4 at 7:45 AM | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Holdings Cut by Ally Bridge Group NY LLCAlly Bridge Group NY LLC lowered its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 24.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 114,360 shares of the biopharmaceutical cMay 4 at 7:45 AM | marketbeat.comFirst Trust Advisors LP Trims Stock Position in Insmed Incorporated (NASDAQ:INSM)First Trust Advisors LP decreased its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 76.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 66,690 shares of the biopharmaceutical company's stock after selliMay 4 at 3:53 AM | marketbeat.comPublic Employees Retirement Association of Colorado Acquires 5,639 Shares of Insmed Incorporated (NASDAQ:INSM)Public Employees Retirement Association of Colorado boosted its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 40.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,574 shaMay 3 at 5:31 AM | marketbeat.comWilliam Lewis Sells 6,830 Shares of Insmed Incorporated (NASDAQ:INSM) StockMay 3 at 5:13 AM | insidertrades.comInsmed (INSM) Projected to Post Earnings on ThursdayInsmed (NASDAQ:INSM) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-insmed-incorporated-stock/)May 3 at 4:30 AM | marketbeat.comIs Insmed Gaining or Losing Market Support?May 2 at 11:37 AM | benzinga.comOne68 Global Capital LLC Invests $345,000 in Insmed Incorporated (NASDAQ:INSM)One68 Global Capital LLC acquired a new position in Insmed Incorporated (NASDAQ:INSM - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 5,000 shares of the biopharmaceutical company's stoMay 2 at 8:19 AM | marketbeat.comSoros Fund Management LLC Has $31.42 Million Stock Holdings in Insmed Incorporated (NASDAQ:INSM)Soros Fund Management LLC trimmed its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 4.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 455,089 shares of the biopharmaceutical companyMay 1, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) is Darwin Global Management Ltd.'s Largest PositionDarwin Global Management Ltd. boosted its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 23.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 12,960,538 shares of the biopharmaceutical company's stock afterMay 1, 2025 | marketbeat.comInsmed Inc.April 30, 2025 | marketwatch.comInsmed Incorporated (INSM): Among Billionaire George Soros’ Mid-Cap Stocks With Huge Upside PotentialApril 30, 2025 | msn.comInsmed Incorporated (NASDAQ:INSM) Stake Lessened by Emerald Mutual Fund Advisers TrustEmerald Mutual Fund Advisers Trust trimmed its position in Insmed Incorporated (NASDAQ:INSM - Free Report) by 17.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 400,624 shares of the biopharmaceutical company's stock after selling 87,040 shares dApril 30, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Holdings Cut by First Light Asset Management LLCFirst Light Asset Management LLC cut its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 31.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 470,192 shares of the biopharmaceutical company's stock aApril 30, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Shares Acquired by Artia Global Partners LPArtia Global Partners LP increased its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 217.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 167,939 shares of the biopharmaceutical company'sApril 29, 2025 | marketbeat.comInsmed To Present at the BofA Securities 2025 Health Care ConferenceApril 29, 2025 | prnewswire.comAquatic Capital Management LLC Purchases 68,268 Shares of Insmed Incorporated (NASDAQ:INSM)Aquatic Capital Management LLC raised its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 296.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 91,268 shares of the biopharmaceuApril 29, 2025 | marketbeat.comRenaissance Technologies LLC Buys New Shares in Insmed Incorporated (NASDAQ:INSM)Renaissance Technologies LLC bought a new stake in Insmed Incorporated (NASDAQ:INSM - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 25,287 shares of the biopharmaceutical company's stock, valuedApril 29, 2025 | marketbeat.com270,960 Shares in Insmed Incorporated (NASDAQ:INSM) Acquired by Susquehanna Fundamental Investments LLCSusquehanna Fundamental Investments LLC acquired a new stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 270,960 shares of the biApril 28, 2025 | marketbeat.comSyon Capital LLC Makes New Investment in Insmed Incorporated (NASDAQ:INSM)Syon Capital LLC bought a new stake in Insmed Incorporated (NASDAQ:INSM - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 5,276 shares of the biopharmaceutical company'sApril 28, 2025 | marketbeat.comInsmed (NASDAQ:INSM) Sees Large Volume Increase - What's Next?Insmed (NASDAQ:INSM) Sees Unusually-High Trading Volume - Time to Buy?April 27, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Shares Sold by T. Rowe Price Investment Management Inc.T. Rowe Price Investment Management Inc. reduced its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 12.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,982,707 shares of the biopharmaceutical company'sApril 27, 2025 | marketbeat.comInsmed: Poised For Transformation Beyond ARIKAYCEApril 26, 2025 | seekingalpha.comPrice T Rowe Associates Inc. MD Buys 123,429 Shares of Insmed Incorporated (NASDAQ:INSM)Price T Rowe Associates Inc. MD increased its position in Insmed Incorporated (NASDAQ:INSM - Free Report) by 1.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,704,410 shares of tApril 26, 2025 | marketbeat.comTower Research Capital LLC TRC Purchases 16,194 Shares of Insmed Incorporated (NASDAQ:INSM)Tower Research Capital LLC TRC raised its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 706.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 18,487 shares of the biopharmaceutical company's sApril 26, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Position Increased by Mariner LLCMariner LLC lifted its position in Insmed Incorporated (NASDAQ:INSM - Free Report) by 23.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 30,788 shares of the biopharmaceutical compApril 26, 2025 | marketbeat.comInvestors Purchase Large Volume of Call Options on Insmed (NASDAQ:INSM)April 26, 2025 | americanbankingnews.comAdage Capital Partners GP L.L.C. Has $113.75 Million Stake in Insmed Incorporated (NASDAQ:INSM)Adage Capital Partners GP L.L.C. lifted its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 59.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,647,562 shares of the biopharmaceutical comApril 25, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) is Hood River Capital Management LLC's 10th Largest PositionHood River Capital Management LLC lifted its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 3.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,525,628 sharesApril 25, 2025 | marketbeat.comLong Focus Capital Management LLC Has $44.93 Million Position in Insmed Incorporated (NASDAQ:INSM)Long Focus Capital Management LLC lifted its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 3.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 650,800 shares of the biopharmaceutiApril 25, 2025 | marketbeat.comMetLife Investment Management LLC Raises Stock Holdings in Insmed Incorporated (NASDAQ:INSM)MetLife Investment Management LLC lifted its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 15.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 103,429 shares of the biopharmaceuApril 25, 2025 | marketbeat.comEliem Therapeutics (NASDAQ:ELYM) and Insmed (NASDAQ:INSM) Head to Head SurveyApril 25, 2025 | americanbankingnews.comNovel DPP-1 Drug Trims Exacerbation Risk in BronchiectasisApril 24, 2025 | msn.comHC Wainwright Reiterates Buy Rating for Insmed (NASDAQ:INSM)HC Wainwright reissued a "buy" rating and issued a $90.00 target price on shares of Insmed in a research note on Tuesday.April 24, 2025 | marketbeat.comSilverarc Capital Management LLC Has $25.70 Million Holdings in Insmed Incorporated (NASDAQ:INSM)Silverarc Capital Management LLC boosted its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 7.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 372,230 shares of the biopharmaceutical company's stApril 24, 2025 | marketbeat.comInsmed Announces Redemption of all $569.5 Million of Remaining Outstanding 0.75% Convertible Senior Notes Due 2028April 24, 2025 | prnewswire.comBI Asset Management Fondsmaeglerselskab A S Buys Shares of 31,390 Insmed Incorporated (NASDAQ:INSM)BI Asset Management Fondsmaeglerselskab A S purchased a new position in Insmed Incorporated (NASDAQ:INSM - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 31,390 shares of the biopharmaceutical company'sApril 24, 2025 | marketbeat.comInsmed says NEJM publishes ‘positive’ results from Phase 3 ASPEN studyApril 23, 2025 | msn.comInsmed Incorporated (INSM): Among Takeover Rumors Hedge Funds Are BuyingApril 23, 2025 | msn.comNew England Journal of Medicine Publishes Positive Results from Insmed's Pivotal Phase 3 ASPEN Study of Brensocatib in Patients with BronchiectasisApril 23, 2025 | prnewswire.comInsmed to Host First-Quarter 2025 Financial Results Conference Call on Thursday, May 8, 2025April 23, 2025 | prnewswire.comRock Springs Capital Management LP Decreases Position in Insmed Incorporated (NASDAQ:INSM)Rock Springs Capital Management LP cut its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 19.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 550,000 shares of the biopharmaceutical company's stApril 23, 2025 | marketbeat.comB Group Inc. Makes New $24.16 Million Investment in Insmed Incorporated (NASDAQ:INSM)B Group Inc. purchased a new stake in Insmed Incorporated (NASDAQ:INSM - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The fund purchased 350,000 shares of the biopharmaceutical company's stock, valued at approximately $24,164,000. Insmed comprises 14.8% ofApril 23, 2025 | marketbeat.comSenator Investment Group LP Makes New $8.29 Million Investment in Insmed Incorporated (NASDAQ:INSM)Senator Investment Group LP bought a new position in Insmed Incorporated (NASDAQ:INSM - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 120,000 shares of the biopharmaceuticApril 23, 2025 | marketbeat.comCapital International Investors Has $491.36 Million Stake in Insmed Incorporated (NASDAQ:INSM)Capital International Investors grew its position in Insmed Incorporated (NASDAQ:INSM - Free Report) by 9.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 7,116,997 shares of the biopharmaceutical company's stock after purchasing an aApril 21, 2025 | marketbeat.comMarshall Wace LLP Buys 293,004 Shares of Insmed Incorporated (NASDAQ:INSM)Marshall Wace LLP raised its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 38.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,064,215 shares of the biopharmaceutical company's stockApril 19, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) CEO Sells $479,192.80 in StockInsmed Incorporated (NASDAQ:INSM - Get Free Report) CEO William Lewis sold 6,830 shares of Insmed stock in a transaction dated Tuesday, April 15th. The stock was sold at an average price of $70.16, for a total value of $479,192.80. Following the completion of the transaction, the chief executive officer now owns 233,924 shares of the company's stock, valued at $16,412,107.84. This trade represents a 2.84 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.April 18, 2025 | marketbeat.comEAM Global Investors LLC Decreases Stock Position in Insmed Incorporated (NASDAQ:INSM)EAM Global Investors LLC decreased its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 35.2% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 61,489 shares of the biopharmaceutical company's stock after selling 33,353 shares duApril 18, 2025 | marketbeat.com Get Insmed News Delivered to You Automatically Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter. Email Address INSM Media Mentions By Week INSM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INSM News Sentiment▼1.210.73▲Average Medical News Sentiment INSM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INSM Articles This Week▼2311▲INSM Articles Average Week Get Insmed News Delivered to You Automatically Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News Today Alnylam Pharmaceuticals News Today Beigene News Today Royalty Pharma News Today Summit Therapeutics News Today Teva Pharmaceutical Industries News Today Intra-Cellular Therapies News Today Genmab A/S News Today United Therapeutics News Today BioMarin Pharmaceutical News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INSM) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Insmed Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Insmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
